ARCHIVES

Nevins Retracts Key Paper By Duke Group, Raising Question Of Harm To Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 39 | October 29, 2010

Download PDF Visit The Full Archive

Related Articles

Bush Administration proposes 2.7 percent increase for NIH in fiscal year 2005; NIH budgets listed by institute.

February 6, 2004

AstraZeneca To Pay $335M In Illegal Pricing Penalties.

June 27, 2003

NCI-Approved Clinical Trials

December 30, 2005

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

October 26, 2001

Genomic Tests Not Shown To Decrease Deaths, Improve Quality Of Life

October 27, 2006

NCI Announces New CREG Offer For In Vitro Chemical Carcinogenesis Tests

November 21, 1975